Minocycline: neuroprotective mechanisms in Parkinson's disease.
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D006801:Humans; D008911:Minocycline / Q000009:adverse effects / Q000494:pharmacology*; D008928:Mitochondria / Q000502:physiology; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000494:pharmacology*; D018384:Oxidative Stress; D010300:Parkinson Disease / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D008911:Minocycline